959786-40-4 Usage
Description
d2-2-(4-benzyloxy-phenyl)-ethanol is a chemical compound with the molecular formula C16H18O2. It is a diastereoisomer of 2-(4-benzyloxyphenyl)ethanol, with two different stereoisomers. It has a unique molecular structure and properties that make it valuable in various applications.
Used in Pharmaceutical Industry:
d2-2-(4-benzyloxy-phenyl)-ethanol is used as a key intermediate in the synthesis of colchicine derivatives, which have potential anti-cancer properties. Its unique molecular structure allows for the development of new drugs with improved efficacy and reduced side effects.
Used in Chemical Research:
d2-2-(4-benzyloxy-phenyl)-ethanol is used in the preparation of other chemical compounds for pharmaceutical and chemical research purposes. Its unique properties make it a valuable tool for studying various chemical reactions and processes.
Used in Synthesis of Other Compounds:
d2-2-(4-benzyloxy-phenyl)-ethanol has the potential for various applications in the pharmaceutical and chemical industries due to its unique molecular structure and properties. It can be used in the synthesis of other compounds with potential therapeutic or industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 959786-40-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,7,8 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959786-40:
(8*9)+(7*5)+(6*9)+(5*7)+(4*8)+(3*6)+(2*4)+(1*0)=254
254 % 10 = 4
So 959786-40-4 is a valid CAS Registry Number.
959786-40-4Relevant articles and documents
DEUTERATED AMINOGLYCIDYL COMPOUNDS
-
, (2008/06/13)
Provided herein are substituted aminoglycidyl compounds of Formula (1), processes of preparation, and pharmaceutical compositions thereof and methods of their use for treating, preventing, or ameliorating one or more symptoms of a social anxiety disorder, an anxiety disorder, hyperthyroidism, tremor, glaucoma, hypertension, coronary artery bypass graft, chronic stable angina, atrial arrhythmia, migraine, bleeding esophageal varices, hypertrophic subaortic stenosis, heart failure, post-myocardial infarction, decreased left ventricular function after recent myocardial infarction, and/or any disorder ameliorated by beta adrenergic receptor modulators.
